Saeed Karimi Motaleb

[ 1 ] - Evaluation of the therapeutic effect of coenzyme Q10 in patients with generalized vitiligo

Background: Vitiligo is a skin autoimmune disease that affects 0.1% to more than 8% of people in the world. About 50% of patients develop the disease before the age of 20. In this disease, melanocytes are destroyed in the skin, mucous membranes and retina. As a result, white spots appear on different parts of the body. Studies have suggested the role of oxidative stress in vitiligo. Coenzyme Q1...